Delivery Order SPE2DB22D3004-SPE2DB24FRY40

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,508.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,362,864 units of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, with a performance period through August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $6,334.74 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,556,926,723 units of Tresiba FlexTouch 200 unit/mL 3mL insulin medication. This delivery order is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $1,334.04 firm fixed price delivery order contract to AmerisourceBergen Drug Corp to supply Tresiba FlexTouch 100 Unit/mL 3mL insulin products. This delivery order is under a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999, which enables the government to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. The award does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,200.93 worth of Tresiba FlexTouch 200 unit/mL 3mL insulin products. The order has an ultimate completion date of April 8, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/ml 3ml insulin medication. The $9,199.44 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,227.27 order is for Tresiba FlexTouch 100 Unit/ML 3ML insulin cartridges. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML insulin medication. The $18,948.75 firm-fixed-price contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $2,699.85 order is for the supply of Tresiba FlexTouch, a prescription insulin medication, to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,001.06 firm fixed price contract is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL, a brand name insulin product, with a period of performance through March 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,401.86 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Tresiba FlexTouch 200 Unit/mL 3mL pharmaceutical products. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRY40
    Delivery Order

This is a $1,601.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,925,708 units of Tresiba FlexTouch 200 Unit/ML 3ML insulin medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, to various defense and civilian agencies. This contract award does not have a set-aside designation.

Generated 12/24/24, 9:38 AM